Assessing the potential of GBS maternal immunisation in preventing maternal infection and foetal harm

10/8/2018

Presented by Theresa Lamagni, MSc PhD HonMFPH

Measurable Learning Objectives:
At the conclusion of this presentation, participants should be able to…
1. Discuss that the incidence of maternal GBS sepsis in England was identified as 1 in 3500
2.Recall that foetal outcomes in these women were significantly poorer than background rates

ABOUT THE PRESENTER:

Theresa Lamagni, MSc PhD HonMFPH
Theresa Lamagni, MSc PhD HonMFPH, is a Senior Epidemiologist and Section Head working at Public Health England (PHE). She has worked in public health for over 20 years. During this time she completed an MSc in Epidemiology at the London School of Hygiene & Tropical Medicine and a PhD at the University of Helsinki. She has authored over 100 peer-review papers, 4 clinical microbiology book chapters and 3 national public health guidelines and sits on the editorial board of the Journal of Antimicrobial Chemotherapy. She is the lead epidemiologist for streptococcal diseases in PHE and currently manages the national Surgical Site Infection Surveillance Service. She is involved in national outbreak and incident response and developing an evidence base to inform disease prevention programmes through national and international and research projects. https://www.researchgate.net/profile/Theresa_Lamagni

Marti Perhach

10/19/2018 09:57:54 am

Thank you, Dr. Lamagni, for your and your team's very important work to assess the potential of GBS maternal immunization and for including miscarriages in your study!

Larry Paoletti

10/20/2018 01:45:31 pm

Very important study. Could you share the other serotypes other than the most common listed (III, Ia, V, and II)? I ask because in the past some serotypes, such as type VIII were found only in Japan (until we published the first report of type VIII in the US). So it would be interesting to know the other serotypes. Thank you and keep up the good work.

Theresa Lamagni

11/6/2018 04:33:24 am

Dear Larry,

The other serotypes were Ib, IV and VI. We have found serotype VIII in invasive GBS isolates the UK in past collections - see Lamagni et al Clin Infect Dis 2013; 57(5):682-8.

All the best,
Theresa

11/6/2018 04:17:45 pm

Thanks Theresa.

Larry

Moderator

10/20/2018 02:38:02 pm

Dr. Lamagni welcomes and appreciates all comments and questions on her presentation and is looking forward to responding on or after the 24th of October.

Comments are closed.